|
NACP100233 |
[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 10-hydroxy-5,9-dimethyl-13-methylene-14-oxo-tetracyclo[10.2.2.01,10.04,9]hexadecane-5-carboxylate |
Prenol lipids |
|
NACP100295 |
8-(isobutylamino)-4,4a,6a,11a-tetramethyl-1,2,5,6,11,11b-hexahydrobenzo[a]fluorene-7,10-dione |
|
|
NACP10030 |
2-(5-hydroxy-3,7-dimethoxy-4-oxo-chromen-2-yl)-3,5-dimethoxy-1,4-benzoquinone |
Benzopyrans |
|
NACP100314 |
methyl 3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-6,8'-dioxo-spiro[cyclohexa-1,4-diene-3,16'-tetracyclo[7.6.1.02,7.010,15]hexadeca-2(7),3,5,10(15),11,13-hexaene]-1'-carboxylate |
Aryltetralin lignans |
|
NACP100318 |
4-methyl-2-(2,3,15-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)hex-4-en-3-one |
Steroids and steroid derivatives |
|
NACP100321 |
6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-7,16-diethyl-4-hydroxy-15-[(5-hydroxy-3,4-dimethoxy-6-methyl-tetrahydropyran-2-yl)oxymethyl]-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione |
Organooxygen compounds |
|
NACP100329 |
2-hydroxy-22-(1-hydroxy-1-methyl-ethyl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.01,18.03,17.04,14.07,12.012,14]tetracosa-4,10-diene-9,16-dione |
Steroids and steroid derivatives |
|
NACP100330 |
3,5-dimethoxy-2-(3-oxo-3-phenyl-propyl)-1,4-benzoquinone |
Organooxygen compounds |
|
NACP100369 |
2,9-dihydroxy-5,10-dimethyl-5-vinyl-17-oxapentacyclo[7.6.2.01,10.02,7.011,13]heptadec-6-ene-8,16-dione |
Lactones |
|
NACP100372 |
1-isopropyl-4-methylene-bicyclo[3.1.0]hexan-3-one |
NaN |